Skip to content

KIAMED

Active Private limited companyfounded 2020active for 6 yearsRue de la Chapelle Saint-Germain 3, 1380 LasneKBO/BCE: BE 0747.768.644

Lifetime

6 annual accounts with figures on one time axis
peak of €442,605 in 2025
€442,605▲ 12.0%
peak of €294,813 in 2021
€157,002▼ 40.3%
peak of €669,873 in 2022
€161,979▲ 33×
€64,314▼ 80.9%
Board1 name since 2020
1 director
Documentsfilings and deeds
30-04-202692 days before the deadline
2025micro format
Gross margin from €395,044 to €442,605Result from €263,015 to €157,002Equity from €4,977 to €161,979Debts from €337,322 to €64,314Cash from €39,396 to €83,678

Key points

from the 2025 annual accounts

Equity

€161,979 ▲ 33×
€4,9802024€162,0002025

Equity rose in 2025 from €4,977 to €161,979.

Turnover

≈ €680,000 estimated

The micro format states no turnover.

Liquidity

2.86 was 0.29 in 2024

Short-term debts fell from €337,322 to €64,314.

Filings

6 annual accounts since 2020
AprilJune31 JulyOctober202020222024

The last five annual accounts were filed 35 to 125 days before the end of the period.

Position in the sector

€157,002

Higher net result than 81% of companies in human health. Sector median €59,542 · 21,323 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,973 companies had the same profile as KIAMED has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,973 companies, not a prediction for KIAMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 02-06-2020
  • 100 sharesdeed of 04-06-2020
Board & ownership

Recent changes

Registered office moved from Schaerbeek to Couture-Saint-Germain The registered office moved from Place Colignon 35- 1030 Schaerbeek to Rue de la Chapelle Saint-Germain 3, 1380 Couture-Saint-Germain · General meeting of 02-01-2026 · Gazette deed
Incorporation Founding capital of €4,000, 100 shares · Founder: (comparant fondateur) · Appointment: (director) · published on 04-06-2020 · Gazette deed
All 13 events

Comparable companies

same main activity, similar in size and age
Company
KIAMED Lasne €226,294 €442,605 71.6% -
Dr. Heidi Debels, Plastische Chirurgie Ghent €198,218 €388,874 36.1% -
DOKTER TRIFONOV SERGEY Antwerp €301,859 €403,663 73.3% -
FERYASU Bertem €320,778 €419,256 0.0% -
RADIA Ramillies €351,305 €365,229 1.4% -
Maison Médicale Passerelle Santé Louvain La Neuve Ottignies-Louvain-la-Neuve €158,343 €518,029 71.8% 6.1
Dr. Cedric Depuydt Kortrijk €269,495 €351,117 96.8% -

These companies have the same main activity as KIAMED: general medical practice (NACE 86210). They are comparable in size and age: total assets between €158,000 and €351,000, founded between 2017 and 2021.

Official details

Source: KBO
Status
Active since 02-06-2020Normal situation
Activity
General medical practiceNACE 86210and 1 other
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€226,294▼ 33.9%
Filing
Filed on 30-04-2026, 92 days before the end of the filing period
Financials

Insights on KIAMED

KIAMED files the micro format. That format states no turnover. The gross margin rose from €160,599 in 2020 to €442,605 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about KIAMED

What is the company number of KIAMED?
The company number of KIAMED is 0747.768.644. The VAT number is the same number with BE in front: BE 0747.768.644.
Where is KIAMED based?
The registered office is at Rue de la Chapelle Saint-Germain 3, 1380 Lasne.Company details
What does KIAMED do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of KIAMED?
KIAMED is a private limited company (BV).
When was KIAMED founded?
KIAMED was founded on 02-06-2020.
Is KIAMED still active?
Yes, KIAMED is an active enterprise in the KBO register.
What is the turnover of KIAMED?
The turnover in financial year 2025 is ≈ €680,000. This figure is estimated from the gross margin of €442,605 and 38 comparable companies (NACE 862). It probably lies between €590,000 and €850,000.Financials
Is KIAMED profitable?
In financial year 2025, KIAMED made a profit of €157,002.
Where can I find the annual accounts of KIAMED?
KIAMED filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of KIAMED due?
KIAMED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.